PainReform Ltd.

NasdaqCM PRFX

PainReform Ltd. Share Price on January 14, 2025: USD 2.74

PainReform Ltd. Share Price is USD 2.74 on January 14, 2025, a -95.16% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

PainReform Ltd. 52-week high Share Price is USD 56.64 on January 16, 2024, which is 1,967.15% above the current Share Price.
PainReform Ltd. 52-week low Share Price is USD 1.80 on November 01, 2024, which is -34.31% below the current Share Price.
PainReform Ltd. average Share Price for the last 52 weeks is USD 18.00.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqCM: PRFX

PainReform Ltd.

CEO	Dr. Ehud Geller Ph.D.
IPO Date	Sept. 1, 2020
Location	Israel
Headquarters	65 Yigal Alon Street
Employees	7
Sector	Health Care
Industries Pharmaceuticals Clinical Trials

Description

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

Key trends

Past 5 years